Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 4679-4685, October 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwarzmeier, J. D.
Right arrow Articles by Berger, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarzmeier, J. D.
Right arrow Articles by Berger, R.

Inadequate Production of Hematopoietic Growth Factors in Hairy Cell Leukemia: Up-Regulation of interleukin 6 by Recombinant IFN-{alpha} in Vitro1

Josef D. Schwarzmeier2, Martin Hilgarth, Son T. Nguyen, Medhat Shehata, Gerhard Gruber, Andreas Spittler, Martin Willheim, Georghe Boltz-Nitulescu, Paul Höcker and Rudolf Berger

Department of Hematology, Clinic of Internal Medicine I [J. D. S., M. H.], Ludwig-Boltzmann Institute for Cytokine Research [J. D. S., M. H., S. T. N., M. S., G. G., R. B.], and Departments of Transfusion Medicine [P. H.] and General and Experimental Pathology [A. S., M. W., G. B-N.], University of Vienna, Vienna A-1090, Austria

The course of hairy cell leukemia (HCL) is characterized by progressive pancytopenia. The pathogenesis of this phenomenon is still not fully understood. To study if the decrease in hematopoiesis in HCL is accompanied by abnormal concentrations of growth factors, we investigated the production of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, interleukin 3 (IL-3), interleukin 6 (IL-6), and tumor necrosis factor {alpha} by peripheral blood mononuclear cells (PBMCs) of eight patients with HCL. The results point to a severe deficiency of production of all cytokines tested as compared to healthy donors. However, enrichment of autologous monocytes by counterflow centrifugation resulted in a marked increase of the levels of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, IL-6, and tumor necrosis factor {alpha}. The most pronounced effects were seen with IL-6. Reverse transcription-PCR analysis indicated that pokeweed mitogen, IFN-{alpha}, and poly(I:C) are capable of inducing the expression of IL-6-specific mRNA in HCL cells. These findings are substantiated on the protein level by immunofluorescence analysis. Incubation of PBMCs with IFN-{alpha} resulted in a significant increase of intracellular IL-6 in HCL but not in healthy donors. This increase was also seen in hairy cells positive for CD19 and CD11c. Furthermore, IFN-{alpha} induced the secretion of IL-6 from PBMCs of HCL patients but not healthy donors. In conclusion, our studies with PBMCs from patients with HCL revealed an inadequate supply of hematopoietic growth factors that might, in part, be due to the monocytopenia characteristic for this disease. The findings also indicate that IFN-{alpha} is capable of inducing the production of IL-6 in the patients' PBMCs as well as in their hairy cells. These data from our in vitro studies support the clinical observation that treatment with IFN-{alpha} leads to reconstitution of hematopoiesis.

1 This work was supported, in part, by Grant 8283 from the Fonds zur Förderung der wissenschaftlichen Forschung and Grant 5198 from the Austrian National Bank.

2 To whom requests for reprints should be addressed, at Department of Hematology and Ludwig-Boltzmann Institute for Cytokine Research, University of Vienna Medical School, Waehringer Guertel 18–20, A-1090 Vienna, Austria. Phone: 43-1-40 400-54 59; Fax: 43-1-40 400-44 61.

Received 4/16/96. Accepted 8/15/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Shehata, J. D. Schwarzmeier, S. T. Nguyen, M. Hilgarth, R. Berger, R. Hubmann, S. Kickmaier, and T. Decker
Reconstitution of Endogenous Interferon {{alpha}} by Recombinant Interferon in Hairy Cell Leukemia
Cancer Res., October 1, 2000; 60(19): 5420 - 5426.
[Abstract] [Full Text]


Home page
BloodHome page
G. Gruber, J. D. Schwarzmeier, M. Shehata, M. Hilgarth, and R. Berger
Basic Fibroblast Growth Factor Is Expressed by CD19/CD11c-Positive Cells in Hairy Cell Leukemia
Blood, August 1, 1999; 94(3): 1077 - 1085.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.